Search
for
Sort by
Research 30 of 1000+
- Skin toxicity of anti‐cancer therapy
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Management of Toxicities of Targeted Therapies
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Valorization of Hom Thong Banana Peel (Musa sp., AAA Group) as an Anti-Melanogenic Agent Through Inhibition of Pigmentary Genes and Molecular Docking Study
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- LAM/TSC Cell Migration to Uterus in an Experimental Model of Lymphangioleiomyomatosis. Regulation by Anti-Epidermal Growth Factor Receptor Antibody and Rapamycin
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- Network pharmacology, molecular docking, and dynamics reveal the mechanisms of Hejie Shengfa Decoction against alopecia areata
- Spermidine Promotes Human Hair Growth and Is a Novel Modulator of Human Epithelial Stem Cell Functions
- When bugs and drugs conspire: driving acneiform skin toxicity
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems
- Flavonoids as Potential Wound-Healing Molecules: Emphasis on Pathways Perspective
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Cosmeceuticals in Dermatology
- Cutaneous drug reactions
- Sesamin alleviates androgenetic alopecia by targeting the AR MAPK Wnt axis
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Plumbagin, a Natural Compound with Several Biological Effects and Anti-Inflammatory Properties
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- Epigallocatechin-Gallate (EGCG): An Essential Molecule for Human Health and Well-Being
- Drug Repurposing Patent Applications April–June 2021